Related Experiment Video
Updated: Sep 1, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Atypical HUS Triggered by COVID-19: A Case Report
Vaibhav Tiwari1, Gaurav Bhandari1, Anurag Gupta1
1Department of Nephrology, Sir Ganga Ram Hospital, New Delhi, India.
Coronavirus disease 2019 (COVID-19) can trigger atypical hemolytic uremic syndrome (aHUS). Genetic analysis revealed complement system mutations, necessitating simultaneous liver and kidney transplants to prevent recurrence.
Area of Science:
- Nephrology
- Infectious Diseases
- Genetics
Background:
- Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening condition characterized by thrombotic microangiopathy.
- Coronavirus disease 2019 (COVID-19) has been associated with various thrombotic complications, including kidney injury.
Observation:
- A 26-year-old male with COVID-19 presented with acute kidney injury and biopsy findings consistent with thrombotic microangiopathy.
- Plasmapheresis treatment did not lead to kidney function recovery.
Findings:
- Genetic analysis identified mutations in complement factor H-related proteins (CFHR1 and CFHR3), confirming a diagnosis of aHUS.
- The patient's aHUS was precipitated by COVID-19 infection.
Implications:
- This case highlights the potential for COVID-19 to trigger aHUS in genetically susceptible individuals.
- Simultaneous liver and kidney transplantation is recommended due to the high risk of aHUS recurrence after live-related kidney transplantation.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Pyelonephritis I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations
Urinary Tract Infection II: Pathophysiology

